Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Infusion During LMA Removal
NCT01303627Phase 4Completed
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- Feb 2011
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in ureterolithiasis, sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Started Feb 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on NCT01303627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303627.